XML 35 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Unaudited Interim Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 211 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Revenue $ 0 $ 0 $ 0
Operating expenses:      
Research and development 32 178 69,797
Impairment of capital assets 0 0 386
Gain on deferred lease inducements 0 0 (497)
Acquired in-process research and development 0 0 13,094
General and administrative 505 359 33,933
Loss from operations (537) (537) (116,713)
Other (expense) income :      
Settlement of Cadherin litigation 0 0 (1,283)
Interest expense 0 0 (19)
Unrealized loss on derivatives (2,655) (3,573) 4,379
Other income 0 0 256
Interest (expense) income and other (2) 2 2,897
Total other (expense) income, net (2,657) (3,571) 6,230
Net loss $ (3,194) $ (4,108) $ (110,483)
Basic and diluted net loss per common share $ (0.11) $ (0.16)  
Weighted-average number of common shares outstanding, basic 29,308 25,158  
Weighted-average number of common shares outstanding, diluted 29,308 25,158